Most study authors at the 2019 Society of Gynecologic Oncology Annual Meeting failed to disclose industry relationships, a study found.
An appreciation of the virtues one wishes to embody can help to navigate the complex ethical dilemmas physicians may face during the COVID-19 crisis.
Meeting public demand for an urgently needed effective medication quickly and safely during a pandemic involves difficult tradeoffs.
Successful smoking cessation involves a 2-pronged approach, since there are 2 components to smoking – physiological and behavioral, according to Nervana Elkhadragy, PharmD, MS, TTS, of Purdue University, College of Pharmacy, Indianapolis.
Physicians should frame treatment options by their “harms and benefits,” not by their “risks and benefits.”
From an ethical perspective, disclosing adverse events to patients is predicated on the idea that physicians have obligations to tell the truth, but physicians may worry that apologizing will incur greater responsibility for liability.
The aim of this qualitative study was to explore the perspectives of clinical trial “stakeholders” regarding enrollment of minorities in cancer clinical trials.
Herein, spiritual care was defined as “that which recognizes and responds to the needs of the human spirit, including the need for meaning, purpose, and connection.”
Unconscious, unacknowledged thoughts and feelings may interfere with fair and objective evaluations of different groups of people.
Managing conflict of interest enables the medical profession to avoid bias in the delivery of patient care while allowing for reasonable financial relationships with industry.